🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#AACR25 Laura Reynolds from our lab present at mini symposium on targeting NELFE using microbubbles in HCC.

Today at #AACR25: Dr. Elda Grabocka is chairing a minisymposia session, “Advances in Cancer Research: Unraveling Tumor Biology, Therapy Resistance, and Novel Models,” at 2:30 pm. abstractsonline.com/pp8/#!/20273/s…

ICYMI at #AACR25: SKCCC researchers presented data showing that large language models (LLMs) can be used to provide dietary recommendations and increase health equity among patients with cancer. abstractsonline.com/pp8/#!/20273/p…

#AACR25: Increased expression of NELFE is associated with poor outcomes in hepatocellular carcinoma (HCC) . A single nucleotide polymorphism (SNP) in NELFE discovered in a subset of HCC patients led to exon 10 skipping, decreased NELFE expression, & improved prognosis.

Targeted delivery of antisense oligonucleotides (ASOs) against exon 10 of NELFE inhibited tumor growth in vivo, making NELFE ASOs a potential therapeutic strategy for HCC, according to a study Laura M. Reynolds Hien Dang, PhD presented at #AACR25. ➡️ abstractsonline.com/pp8/#!/20273/p…

On Saturday, April 26, the Sidney Kimmel Comprehensive Cancer Center at Jefferson Torresdale Hospital hosted our Cancer Prevention Screening & Education Day—providing 100 free screenings to help detect cancer early and save lives. Thank you to our team and community for making it a success!

Join us for The Survivorship Series, presented in partnership with Living Beyond Breast Cancer. This free program offers tips, tools, and real talk on topics to help you feel confident! jeffersonhealth.org/your-health/cl… Sidney Kimmel Comprehensive Cancer Center

👏👏👏

Today on #ClinicalTrialsDay, we celebrate our amazing colleagues throughout the cancer center who are helping to advance cancer care through clinical trials & our incredible patient volunteers. Clinical trials are vital to driving progress against cancer. #CTD2025

Thank you to the staff of Rep. Brian Fitzpatrick 🇺🇸 for taking the time to meet with AACI and AACR members from PA representing Fox Chase Cancer Center and Sidney Kimmel Comprehensive Cancer Center, including directors Dr. Jonathan Chernoff and Dr. Andrew Chapman. #AACIOnTheHill #AACROnTheHill #FundNIH #FundNCI

Follow our IG Stories for updates from #ASCO25 - Dr. Ida Micaily is giving the inside scoop, live from Chicago! Check out our schedule of research presentations here mcusercontent.com/45942701887425…

Honored to present our poster at #ASCO25 on quantifying financial toxicity in oncology using 2022 public data. We explored prescription cost disparities by insurance, income, gender, and geography. Urgent need for policy change to reduce this burden. John Leighton Cherry B

This #NationalCancerSurvivorsDay, we recognize everyone who has been affected by cancer 🎗️ Whether newly diagnosed, in treatment, or navigating life beyond cancer, we will walk with you every step of the way. You inspire us every day and we celebrate your resilience and strength.

#ASCO25: This afternoon, Dr. AnaMaria Lopez is chairing a session reviewing the ASCO-Society for Integrative Oncology guidelines on integrative oncology care for pain, fatigue, anxiety, & depression & will outline communication strategies in the face of limited evidence. meetings.asco.org/2025-asco-annu…

Tomorrow at #ASCO25: Dr. Marlana Orloff is chairing a session outlining the latest developments treating rare #melanoma subtypes & will be leading the discussion on clinical decision-making in #uvealmelanoma in light of new treatment options. More: meetings.asco.org/2025-asco-annu…

Truly inspiring session on the real-world impact of integrative oncology at #ASCO25. 🌿✨ Dr. Krisstina Gowin delivered a masterclass beautifully weaving science with soul while redefining supportive cancer care. From pain to fatigue to depression, this is the future of healing.

#ASCO25: Don't miss the heme malignancies oral abstract session this afternoon! Dr. Margie Kasner is leading a discussion on the future of therapy for acute myeloid leukemia and myelodysplastic syndromes. meetings.asco.org/2025-asco-annu…

CONGRESS | #ASCO25 | POSTER Pierluigi Porcu of Sidney Kimmel Comprehensive Cancer Center, shared long-term results from the phase 2 TELLAMAK study of lacutamab in heavily pretreated pts with R/R Sezary syndrome (n=63). Long-term follow-up data demonstrated high response rate and long-lasting response: